Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA polymerase, RNA-dependent RNA polymerase (RdRp), and Reverse transcriptase (RT) are three distinct classes of enzymes essential for nucleic acid synthesis and viral replication. - DNA polymerases catalyze the synthesis of DNA from a DNA template and are essential in cellular and some viral DNA replication. - RNA-dependent RNA polymerases catalyze the synthesis of RNA from an RNA template; these are critical for the replication of RNA viruses and have no direct counterpart in uninfected mammalian cells. - Reverse transcriptases catalyze the synthesis of complementary DNA from an RNA template (reverse transcription), a process exploited by retroviruses (like HIV), telomerase, and retrotransposons. These enzymes are key targets for antiviral drug development, as specific inhibitors can prevent viral genome replication. Due to their central roles in nucleic acid metabolism, mistargeting can lead to toxicity or off-target effects, particularly for drugs that can also affect human polymerases. The presence or activity of these enzymes is a defining biomarker in monitoring certain infections and in understanding the molecular basis of some cancers.
Inhibition of nucleic acid synthesis via incorporation of chain-terminating nucleoside/nucleotide analogs - Direct enzyme inhibition (active site, allosteric) - Prevention of genome replication or integration
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA polymerase, RNA-dependent RNA polymerase, and Reverse transcriptase.